It is the policy of Lincoln Memorial University (LMU) DeBusk College of Osteopathic Medicine (DCOM) Office of CME to insure balance, independence, objectivity, and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All presenters participating in any sponsored program are expected to verbally disclose to the program audience any real or apparent conflict(s) of interest, or lack thereof, that may have a direct bearing on the subject matter of the continuing education activity. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation.  It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts. It remains for the audience to determine whether the speaker’s outside interests may reflect a possible bias in either the exposition or the conclusions presented.

Terms and Conditions for Faculty Regarding Commercial Support Rules

Disclosure.  Speakers/authors must complete and submit the Disclosure Statement located on the front side of this document prior to the presentation, and ensure that the Disclosure Statement is complete and truthful to the best of the presenter's knowledge.  Faculty members are required to verbally disclose any financial relationships they may have with a manufacturer of any product or class of products they discuss in an educational activity, or the lack of any such relationships.

Fair Balance.  Speakers/authors are required to prepare fair and balanced presentations that are objective and scientifically rigorous. 

Unlabeled and Unapproved Uses.  Presentations that provide information in whole or in part related to non-FDA approved uses for drug products and/or devices must clearly acknowledge the unlabeled indications or the investigational nature of their proposed uses to the audience.  Speakers/authors who plan to discuss non-FDA approved uses for commercial products and/or devices must advise LMU-DeBusk College of Osteopathic Medicine Office of CME of their intent.

Use of Generic versus Trade Names.  Presenters should use scientific or generic names when referring to products in their lectures or enduring materials.  Should it be necessary to use a trade name, then the trade names of all similar products or those within a class should be used.

Commercial Supporter Influence.  Faculty members are not permitted to receive any direct remuneration or gifts from the commercial supporter(s) of this activity as it relates to this specific activity, not should they be subject to direct input from a commercial supporter regarding the content of their presentations.